The progress of Arizona’s bioscience sector is chronicled annually, including key developments and data on jobs, wages, research funding, risk capital, and more.
Current Progress Report
Arizona set another record in National Institutes of Health funding, the gold standard measure of
bioscience research. The $344 million figure for 2022 represents a 12.5% increase over 2021. Learn more about the major bioscience developments and accomplishments across the state by diving into the Latest Progress of the Biosciences in Arizona.
Progress
At the 20-year mark of Arizona’s Bioscience Roadmap, the evidence is overwhelming that consistent strategies, collaboration, and long-term investments are paying off for bio—and for Arizonans. In 2021, Arizona achieved its highest share of NIH funding since the Roadmap began. Bioscience venture capital hit a new high, too. And bio employment continued to grow, paying 31% above the private-sector average.
Progress
The COVID-19 pandemic brought unspeakable suffering to Arizona, and revealed serious challenges in the state’s health-care system, especially for communities of high social vulnerability. But the crisis also brought forth the best from the state’s responsive bioscience sector, as researchers, companies, and health-care leaders made significant contributions to help us navigate 2020.
Progress
For the biosciences in Arizona, 2019 was almost entirely good news. The state’s research enterprise performed better than ever, with all-time highs for National Institutes of Health funding and university R&D. Tech transfer was looking up. Risk capital set a record. And bioscience jobs and wages continued to grow faster than the private sector as a whole. But as 2020 began, a global crisis loomed.
Progress
This 8-page brochure illustrates the importance of the robust bioscience ecosystem here in Arizona and how Arizona’s Bioscience Roadmap Steering Committee is advancing and accelerating this critical ecosystem. The brochure also highlights the advances made in the state’s bioscience sector during 2018 in areas such as entrepreneurism, venture capital, industry, research, education, and clinical care.
Progress
Arizona’s bioscience sector is adding jobs at a rate outpacing the biosciences nationally and the state’s overall private sector, while the state’s public universities are seeing increases in bioscience research funding, expenditures and tech transfer, according to the new data. However, there was a decline in bioscience venture capital over the past two years.
Progress
The year 2016 was highlighted by a $43 million precision-medicine research grant for University of Arizona, TGen’s affiliation with City of Hope and planned Phoenix expansion, the announcement of the Mayo Clinic School of Medicine in partnership with Arizona State University, and the unveiling of plans for a new biotech campus along Tempe Town Lake.
Progress
The state’s bioscience industry continues its strong job and wage growth and had its best venture capital year since 2011, according to the new data. While bio-related university startups continued to increase, there were declines in research dollars and expenditures.
Progress
The year 2014 was highlighted by the merger of Banner Health with the University of Arizona Health Network, construction on the Phoenix Biomedical Campus, progress in planning the Arizona Bioscience Corridor in northeast Phoenix, and the launch of the updated Arizona’s Bioscience Roadmap.
Earlier reports are available on the First Decade page.
